Sign In
Buy NVRO
$5.84
+0 (+0%)
At Close: Jul 01, 2025
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that in its patent litigation agains
Stock Traders Purchase High Volume of Call Options on Nevro (NYSE:NVRO)
05:42am, Thursday, 09'th Apr 2020
Nevro Corp (NYSE:NVRO) saw unusually large options trading on Tuesday. Stock traders acquired 1,222 call options on the stock. This represents an increase of 878% compared to the average volume of 125
Were Hedge Funds Right About Community Bank System, Inc. (CBU) ?
12:43am, Thursday, 09'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Nevro Reports Federal Circuit Rules In Its Favor, Upholds Validity Of Co.'s Patent Claims In Litigation Against Boston Scientific
12:00am, Thursday, 09'th Apr 2020Edited Transcript of NVRO earnings conference call or presentation 21-Feb-19 9:30pm GMT
07:46pm, Wednesday, 08'th Apr 2020
Q4 2018 Nevro Corp Earnings Call
Neurostimulation Devices Market Trends, 2020-2025 - Global Market Expected to Reach $9.6 Billion by 2025 - ResearchAndMarkets.com
11:25am, Wednesday, 08'th Apr 2020
The "Neurostimulation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
Geode Capital Management LLC Has $47.69 Million Stake in Nevro Corp (NYSE:NVRO)
09:44am, Wednesday, 08'th Apr 2020
Geode Capital Management LLC grew its holdings in Nevro Corp (NYSE:NVRO) by 7.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The f
AQR Capital Management LLC Takes Position in Nevro Corp (NYSE:NVRO)
08:36am, Wednesday, 08'th Apr 2020
AQR Capital Management LLC purchased a new stake in Nevro Corp (NYSE:NVRO) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purcha
The "Neurostimulation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
Nevro (NYSE:NVRO) Price Target Lowered to $113.00 at Morgan Stanley
10:20am, Tuesday, 07'th Apr 2020
Nevro (NYSE:NVRO) had its price objective lowered by Morgan Stanley from $118.00 to $113.00 in a report released on Friday, BenzingaRatingsTable reports. The firm currently has an overweight rating on
Nevro (NYSE:NVRO) Stock Price Up 9.1%
06:38am, Tuesday, 07'th Apr 2020
Nevro Corp (NYSE:NVRO)’s stock price rose 9.1% during mid-day trading on Monday . The stock traded as high as $103.08 and last traded at $102.51, approximately 560,388 shares changed hands during tr
Nevro Corp to Post Q1 2020 Earnings of ($0.75) Per Share, Oppenheimer Forecasts (NYSE:NVRO)
05:12am, Monday, 06'th Apr 2020
Nevro Corp (NYSE:NVRO) – Analysts at Oppenheimer increased their Q1 2020 earnings per share estimates for shares of Nevro in a report released on Wednesday, April 1st. Oppenheimer analyst S. Kalia n
Nevro Corp Expected to Earn Q1 2020 Earnings of ($1.10) Per Share (NYSE:NVRO)
05:12am, Monday, 06'th Apr 2020
Nevro Corp (NYSE:NVRO) – Equities researchers at SunTrust Banks lowered their Q1 2020 earnings per share (EPS) estimates for Nevro in a research report issued on Wednesday, April 1st. SunTrust Banks
Nevro (NYSE:NVRO) and Neovasc (NYSE:NVCN) Head-To-Head Contrast
05:30am, Sunday, 05'th Apr 2020
Nevro (NYSE:NVRO) and Neovasc (NASDAQ:NVCN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, instit
Nevro Corp Expected to Post Q2 2021 Earnings of ($0.37) Per Share (NYSE:NVRO)
08:24am, Saturday, 04'th Apr 2020
Nevro Corp (NYSE:NVRO) – SunTrust Banks issued their Q2 2021 earnings per share (EPS) estimates for shares of Nevro in a research report issued on Wednesday, April 1st. SunTrust Banks analyst K. Kru
